MissionIR Articles
-
MissionIRNewsBreaks – FingerMotion Inc.’s (NASDAQ: FNGR) JiuGe Technology, Munich Re Collaborate to Drive Commercial Application of Work
FingerMotion (NASDAQ: FNGR), a mobile data and services company, today announced that its subsidiary, Shanghai JiuGe Information Technology Co. Ltd. (“JiuGe Technology”) and Munich Re, a large global reinsurer, have set the stage for extension…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Poised with Distinct Advantage, Heads to Catalyst-Rich Quarter
EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, is confident that it is heading to a catalyst-rich quarter. “We’re one of the first movers…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces $5M Registered Direct Offering
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced its entry into securities agreements with institutional investors for the purchase and sale of 12,500,000 of the…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Investment Research Report
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, was featured in a recent report published by Zacks Small-Cap Research.…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Former General Motors Federal Government Sales Leader as New GM of Government Sales
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has hired Ronal Dixon as its general manager of government sales; Dixon will focus on U.S. government vehicle procurement programs. With more than four decades…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Latest DehydraTECH-CBD Study May Be 1st to Evidence Sustained Drop in Blood Pressure
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs, has, since inception, been committed to addressing severe unmet patient needs. Hypertension has…
-
MissionIRNewsBreaks – Why Data443 Risk Mitigation Inc. (ATDS) Is ‘One to Watch’
Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company for ALL THINGS DATA SECURITY(TM), is committed to organizing the world’s information by identifying and protecting all sensitive data regardless of location, platform…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Discusses MaaS Business Model, Massive Opportunity on ‘The Shrimp Tank’
Knightscope’s (NASDAQ: KSCP) CEO and Chairman William Santana Li recently appeared on The Shrimp Tank, a podcast series featuring proven entrepreneurs and business leaders discussing how to start, grow and run a successful business. Li…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Preliminary Results from Berubicin Trial
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has released data from its ongoing trial evaluating Berubicin for the…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Showcase Innovative Lidar Solutions at CES 2023
Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, today announced additional details around its plans for the upcoming CES 2023, slated to be held in Las Vegas, Nevada, from Jan. 5-8, 2023.…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Auto Veteran as New VP of Commercial Sales
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that Donald Borthwick, previously head of western sales for Ford, will be its new vice president of commercial sales. With more than two…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K1 Technology for Three New Contracts
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced three new contracts consisting of 13 new K1 Blue Light Towers and three K1 Retrofit Kits. Two of the new clients are colleges…
-
MissionIRNewsBreaks – Vision Energy Corp. (VENG) Announces Symbol Change
Vision Energy (OTCQB: VENG) has announced that, effective at the open of market trading today, its ticker symbol changed from VIHDD to VENG, completing previously reported corporate actions of the company (see news release dated…
-
MissionIRNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Signs Agreement to Build Exclusive AIMIGo 12-Lead 3D VECG Device
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, is partnering with medical device manufacturing company Evolve Manufacturing Technologies to…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Presents CYB003 Preclinical Data Amongst Leading Scientists, Academics in Neuropsychopharmacology
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), announced that it presented two posters on its deuterated psilocybin analog, CYB003, at the American College of Neuropsychopharmacology (“ACNP”) annual…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Findings of Animal Anti-Seizure Study Program Suggesting that DehydraTECH(TM)-CBD Is More Effective at Lower Doses and Works More Rapidly than FDA-Approved Epidiolex
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) formulation has demonstrated performance enhancements compared to Epidiolex(R), the first and only FDA-approved CBD medication for the…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Names Experienced Researcher as Advisory Board Member
BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has appointed a new scientific advisory board member: Dr. Matthias…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate in ‘Ask the CEO’ Event
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Trusted by the Game’s Elite: Newton Golf Company Inc. (NASDAQ: NWTG) Reaches New Milestone
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Paves Way to Redefine Cardiac Care
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Leads U.S. Effort to Reduce REE Dependence with Transformative Technology
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Announces $1.74 Million Grant to Advance Nova Scotia Community Solar Projects, for Which PowerBank is Lead Developer
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Showcases New Products and Growth Strategy at Mid-States 2025 Rendezvous